MARKET

ERNAW

ERNAW

Ernexa Therapeutics Inc
NASDAQ
0.0620
0.00
0.00%
Opening 09:30 06/26 EDT
OPEN
--
PREV CLOSE
0.0620
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
0.2278
52 WEEK LOW
0.0213
MARKET CAP
--
P/E (TTM)
-0.0020
1D
5D
1M
3M
1Y
5Y
1D
Ernexa expects FDA review of ERNA-101 IND in Q4 2026
PUBT · 06/17 13:27
ERNEXA THERAPEUTICS - PLANS IND SUBMISSION FOR ERNA-101 IN Q3 2026 AND PHASE 1 STUDY IN Q4 2026
Reuters · 06/17 12:48
Ernexa Therapeutics announces annual shareholder meeting
PUBT · 05/11 21:11
Ernexa Q1 net loss narrows 32.87% to $5.51 million; no revenue
PUBT · 05/11 21:03
Ernexa Therapeutics to join Virtual Investor Closing Bell event
PUBT · 05/11 13:16
BUZZ-U.S. STOCKS ON THE MOVE-Instacart, New York Times, Novavax
Reuters · 05/06 17:51
Ernexa reports ERNA-101 plus PD-1 blockade clears tumors in ovarian cancer models
PUBT · 05/06 12:33
Ernexa Therapeutics announces 1-for-25 reverse stock split to regain Nasdaq compliance
Seeking Alpha · 04/30 13:11
More

Webull offers Ernexa Therapeutics Inc stock information, including NASDAQ: ERNAW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ERNAW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ERNAW stock methods without spending real money on the virtual paper trading platform.